EUVIMEDEUVIMED entdecken
Crossref

Borderline tumours of the ovary: A 37‐year experience at a tertiary referral centre

Rosie McBain iD, Aidan Kashyap, Milly Bishop, Estefania Vicario, Mila Volchek, Yael Naaman, Niveditha Rajadevan, Antonia Jones, Deborah Neesham, Orla McNally

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025-02 · 65 (1) · 163-172

DOI: 10.1111/ajo.13876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 21.10.2024. Verfasst von Rosie McBain und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Borderline ovarian tumours ( BOT ) are a common epithelial ovarian tumours. Typically diagnosed at an early stage with a good prognosis, many BOT are treated conservatively. Recurrence is common. This update to our last audit in 1997 represents one of the largest audits of BOT to date. Materials and Methods All patients with BOT managed at ‘the hospital’ from 1984 to 2021 were included. Expert pathology review was available.

Results

There were 549 cases included. The recurrence rate was 5% ( n = 29/549) with 1.4% ( n = 8/549) undergoing malignant transformation. Three of the eight women who recurred as cancer died from their disease. Frozen section was predictive of histologic diagnosis in 92% ( n = 55/60) of serous tumours (SBOT), but only 62% ( n = 54/87) of mucinous tumours (MBOT). In MBOT where the appendix appeared normal intra‐operatively, it was histologically benign in all cases ( n = 63). In SBOT, the recurrence rate was 5/23 (22%), 12/52 (23%), 1/29 (3%) and 3% ( P =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsNeoplasm Recurrence, LocalCarcinoma, Ovarian EpithelialHumansFemaleTertiary Care CentersAdultMiddle AgedAgedRetrospective StudiesYoung AdultFrozen Sections

Stichwörter der Autor:innen

appendicectomyborderline ovarian tumoursfertility‐preserving surgerymalignant transformationrestaging surgerysurgical staging

Autor:innen und Institutionen

  • Department of Oncology and Dysplasia, Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Rosie McBain

Zitieren

APA

McBain, R., Kashyap, A., Bishop, M., Vicario, E., Volchek, M., Naaman, Y., Rajadevan, N., Jones, A., Neesham, D., & McNally, O. (2025). Borderline tumours of the ovary: A 37‐year experience at a tertiary referral centre. Australian and New Zealand Journal of Obstetrics and Gynaecology, 65(1), 163-172. https://doi.org/10.1111/ajo.13876

Vancouver

McBain R, Kashyap A, Bishop M, Vicario E, Volchek M, Naaman Y, et al. Borderline tumours of the ovary: A 37‐year experience at a tertiary referral centre. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025;65(1):163-172. doi:10.1111/ajo.13876

BibTeX
@article{McBain2025,
  author = {McBain, Rosie and Kashyap, Aidan and Bishop, Milly and Vicario, Estefania and Volchek, Mila and Naaman, Yael and Rajadevan, Niveditha and Jones, Antonia and Neesham, Deborah and McNally, Orla},
  title = {Borderline tumours of the ovary: A 37‐year experience at a tertiary referral centre},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2025},
  volume = {65},
  number = {1},
  pages = {163--172},
  doi = {10.1111/ajo.13876}
}
Kostenlos starten →